Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Galleon Bio
Newark, New Jersey, United Statesgalleonbio.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
Galleon Bio is developing innovative topical therapies for neuropathic pain and inflammatory skin conditions. The company appears to be in early development stages, with no disclosed clinical results or late-stage pipeline assets.
- Therapeutic areas
- DermatologyNeurology
- Modalities
- Topical therapySmall molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Galleon Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Galleon Bio.